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The effects of aurothiomalate (ATM) and auranofin (AF) on adjuvant-induced 
polyarthritis and serum gold levels were studied in Dark Agouti (DA), Ginger Hooded 
(GH), and J C Lewis (JCL) rats given adjuvants constituted from heat-killed 
Mycobacterium tuberculosis (TBC) in squalane (TBC/SQ), TBC in triolein 
(TBC/TO), or CP20961 in squalane (CP/SQ). Despite the total dose of gold being the 
same in animals treated with ATM or AF, the serum gold levels were consistently 
lower with AF. Moreover, there were no differences in serum gold levels between the 
different rat strains or changes after administration of different adjuvants. In DA rats, 
AF suppressed the arthritis induced by all three adjuvants, but ATM was effective 
only against disease produced by TBC/SQ and TBC/TO. In GH rats, animals given 
TBC/TO did not develop arthritis and were unaffected by AF or ATM; but arthritis 
induced by TBC/SQ or CP/SQ was suppressed by AF but not by ATM. In JCL rats 
arthritis induced by TBC/SQ was potentiated by ATM and suppressed by AF; 
however, animals given TBC/TO did not develop arthritis unless treated with ATM, 
and animals given CP/SQ did not develop arthritis with or without gold treatments. 
 
Thus ATM and AF have ambivalent effects in adjuvant-induced polyarthritis 
depending on the combination of the strain of rat and type of adjuvant used. 
Paradoxically ATM may provoke, potentiate, or inhibit the disease, depending upon 
the strain-adjuvant combination used. The findings support the concept that ATM and 
AF have different modes of action, and that the responsiveness to arthritogens and 
gold drugs may be genetically determined. 
 
